Pulmonary Disease, Chronic ObstructiveNCT03663569
A Study on the Control of Chronic Obstructive Pulmonary Disease (COPD) in Patients Taking the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler
An observational study of Pulmonary Disease, Chronic Obstructive, run by Boehringer Ingelheim at 388 sites in 11 countries.
Trial summary
Open-label observational study which includes COPD patients that are receiving treatment with Spiolto® Respimat® for approximately 6 weeks, which is the average time between two medical consultations. Read more about this study
- Who is it for?
- Ages 40 years and older
- Conditions the study is for
- Pulmonary Disease, Chronic Obstructive
- What is being tested?
- Spiolto® Respimat®
- How many people
- 4,819 participants
- Where
- 388 sitesin 11 countries
- Study dates
- 15 Aug 2018to 4 Oct 2019
- Phase
- Observational
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Around 4500 COPD patients from approximately 11 countries will be collected, with a signed informed consent will be maintained in the ISF at the investigational site irrespective of whether they have been treated or not.
Who may be able to join
- Written informed consent prior to participation
- Female and male patients ≥40 years of age
- Patients diagnosed with COPD and based upon the investigator's decision requiring a new prescription of Spiolto Respimat® (combination of two long-acting bronchodilators) according to Spiolto® Respimat® SmPC, GOLD COPD Strategy Document 2018 (GOLD COPD groups B to D) and local COPD guidelines
Who cannot join
- Patients with contraindications according to Spiolto® Respimat® SmPC
- Patients already on a LABA/LAMA combination (free and fixed dose) in the last 6 weeks before study entry
- Patients continuing LABA/ICS treatment should not be additionally treated with Spiolto® Respimat® in order to avoid a double dosing of long-acting beta-agonists
- Pregnancy and lactation
- Current participation in any clinical trial or any other non-interventional study of a drug or device.
Trial locations and contacts
388 sites in 11 countries.
388 sites in 11 countries
Russia122 sites
Treatment and consultation center
Angarsk, 665831
Volga district hospital
Astrakhan, 414018
Alexander Mariinsky regional clinical hospital
Astrakhan, 414056
Departmental clinical hospital on the station Barnaul of OJSC "RZhD"
Barnaul, 656000
Barnaul city hospital Nr.5
Barnaul, 656045
Out-patient hospital "Harmony of health"
Belgorod, 308015
Bryansk regional hospital No. 1
Bryansk, 214028
Chekhov central district out-patient hospital
Checkov 2, 142302
Chelyabinsk regional clinical hospital
Chelyabinsk, 454076
Road clinical hospital at station Chelyabinsk RRR
Chelyabinsk, 454091
LLC "AllergoStop", Center of asthma prophylactic and treatment of allergy and asthma
Chelyabinsk, 454106
Regional Clinical Hospital Nr.3
Chelyabinsk, 454106
Institution of public health City clinical hospital #11
Chelyabinsk, 454219
Regional oncology dispensary
Irkutsk, 644032
Irkutsk state clinical hospital Nr.1
Irkutsk, 664046
East and Siberian institute of medical and ecological studies
Irkutsk, 665827
LLC Pulsar
Iskitim, 633000
City clinical hospital No. 4
Ivanovo, 153005
Kaluga regional clinical hospital
Kaluga, 248007
LLC "City Clinical hospital #12"
Kazan', 420036
Medical Association "Spasenie"
Kazan', 420059
City clinical hospital Nr. 16
Kazan', 420064
State autonomy institution of public health
Kazan', 420064
Kemerovo regional clinical phthisiopulmonology medical center
Kemerovo, 650036
Regional clinical hospital of emergency medical care named after M.A. Podgorbunsky
Kemerovo, 650993
LLC "Doctor Lite"
Kirov, 610000
Kirov clinical and diagnostic centeron the basis of out-patient hospital Nr. 1
Kirov, 610050
Krai clinical hospital Nr. 1 named after prof. S.V. Ochapovskogo
Krasnodar, 350086
Krai clinical hospital
Krasnoyarsk, 660022
Krasnoyarsk inter-district clinical hospital Nr. 20 named after I.S. Berzon
Krasnoyarsk, 661123
Kurgan out-patient hospital
Kurgan, 640000
Kurgan regional clinical hospital
Kurgan, 640000
Out-patient hospital of regional budgetary institution of public health
Kursk, 305004
Medassist-K
Kursk, 306900
Lipetsk city out-patient hospital Nr. 7
Lipetsk, 398046
Republican clinical hospital of war and labor veterans
Makhachkala, 367000
Educational institution of higher education named after N.I. Pirogov of Ministry of health of Russia
Moscow, 105077
Moscow scientific and clinical educational center for respiratory medicine
Moscow, 105077
City out-patient hospital Nr. 22 of department of public health of Moscow, branch Nr. 2
Moscow, 117449
City out-patient hospital Nr. 134 of department of public health of Moscow
Moscow, 117463
City out-patient hospital Nr. 52 of department of public health of Moscow
Moscow, 117546
First Moscow State Medical University named after I. M. Sechenov
Moscow, 119991
Institution of public health "City out-patient hospital #180 of department of public health of Moscow
Moscow, 125222
Consultation and diagnostic center Nr. 6 of department of public health of Moscow
Moscow, 127540
Moscow Regional Research Clinical Institute named after M.F. Vladimirsky
Moscow, 129110
Nizhnevartovsk county hospital No.2
Nizhnevartovsk, 628624
Nizhny Novgorod scientific and research institute of sanitary science and occupational pathology
Nizhny Novgorod, 603005
Privolzhsky Research Medical University
Nizhny Novgorod, 603005
Nizhny Novgorod city clinical hospital named after N.A. Semashko
Nizhny Novgorod, 603093
Novokuznetsk city clinical hospital Nr. 29
Novokuznetsk, 654038
Azbuka zdoroviya
Novosibirsk, 360000
Road clinical hospital on station Novosibirsk-Main of OJSC "RZhD"
Novosibirsk, 360003
City clinical hospital No. 2
Novosibirsk, 360051
Zdorovaya Semiya
Novosibirsk, 630099
Scientific and research institute of physiology and fundamental medicine
Novosibirsk, 630117
City clinical out-patient hospital No. 1
Novovsibirsk, 630099
Clinical medical sanitary station Nr. 7
Omsk, 644000
City out-patient hospital No. 2
Omsk, 644009
Multifunctional center of modern medicine "Evromed"
Omsk, 644024
ZAO "Multifunctional center of modern medicine "Evromed"
Omsk, 644033
Orenburg regional clinical hospital No. 2
Orenburg, 460000
City hospital named after S. P. Botkin
Oryol, 302000
Penza regional clinical hospital named after N.N. Burdenko
Penza, 440026
Clinical hospital No. 6 named after G.A. Zakhariyn
Penza, 440071
City clinical out-patient hospital of Perm
Perm, 614000
Perm clinical center of federal medical and biological agency "Medical sanitary station #140" on the basis of out-patient hospital #2
Perm, 614038
City clinical out-patient hospital #2
Perm, 614066
"City out-patient hospital #7" on the basis of out-patient hospital #2
Perm, 614070
City clinical out-patient hospital No. 4
Perm, 614097
Perm regional clinical hospital
Perm, 614990
Hospital of Karelia republic named after V.A.Baranov
Petrozavodsk, 185007
1586 military clinical hospital of Ministri of Public Defense
Podolsk, 142110
Treatment and prophylactic institution of union health resort "Rodnik"
Pyatigorsk, 357500
Clinical and diagnostic center "Zdorovie" of Rostov-on-Don
Rostov-on-Don, 344011
Rostov regional clinical hospital
Rostov-on-Don, 344015
City clinical hospital No. 20 of Rostov-on-Don"
Rostov-on-Don, 344091
Regional clinical cardiology dispensary
Ryazan, 390026
Regional clinical hospital
Ryazan, 390039
ZAO "Medi"
Saint Petersburg, 191025
LLC "Medical center XXI century" Bryanseva 13"
Saint Petersburg, 191952
Aleksandrovskaya City Hospitel
Saint Petersburg, 193312
City Consultative and Diagnostic Centre Nr. 1
Saint Petersburg, 194354
Institute of Medical Trials
Saint Petersburg, 196084
First Saint-Petersburg state medical university named after acad. I.P.Pavlov
Saint Petersburg, 197022
Samara city out-patient hospital No.1
Samara, 443000
Samara medical and sanitary unit Nr. 5 of the Kirovsky district
Samara, 443051
City clinical hospital Nr 4 of Samara
Samara, 443056
Samara city hospital Nr. 13 of Zheleznodorozhny district
Samara, 443069
Samara city clinical out-patient hospital No.15
Samara, 443111
National Mordovia research state university named after N.P. Ogarev
Saransk, 430005
Saratov city out-patient hospital Nr. 9
Saratov, 410033
Saratov city clinical hospital No. 8
Saratov, 410052
Saratov city out-patient hospital Nr. 10
Saratov, 410053
Simferopol city clinical hospital Nr. 7
Simferopol, 295024
Simferopol clinical hospital
Simferopol, 950000
Out-patient hospital #5
Smolensk, 214000
Clinical hospital No. 1
Smolensk, 214012
Stavropol krai clinical hospital
Stavropol, 355030
Tambov regional clinical hospital named after V.D. Babenko
Tambov, 392000
Tolyatti city hospital Nr. 5
Tolyatti, 445039
Treatment and diagnostic center
Tomsk, 634012
Out-patient hospital No. 1
Tomsk, 634050
Tomsk Regional clinical hospital
Tomsk, 634063
Federal state budgetary institution of SibFNKC FMBA of Russia
Tomsk, 636037
City hospital Nr. 9
Tula, 300002
Regional Clinical Hospital
Tver', 170036
Regional hospital No. 19 Out-patient hospital
Tyumen, 625017
City clinical hospital Nr. 21
Ufa, 450071
Republican clinical hospital named after G.G. Kuvatov
Ufa, 450071
Vladimir Regional clinical hospital
Vladimir, 600023
Volgograd regional clinical hospital Nr. 1
Volgograd, 400081
Non-state institution of public health Divisional clinical hospital on station Volgograd-1 of OJSC "RZhD"
Volgograd, 400120
Institution of public health of Voronezh region "Voronezh regional clinical consultation and diagnostic center"
Voronezh, 394018
LLC medical center "Diagnostic plus"
Voronezh, 394026
Institution of public health of Yaroslavl region Regional clinical hospital
Yaroslavl, 150062
LLC Medical unity "Novaya Bolnitsa
Yekaterinburg, 320109
Sverdlovsk regional hospital Nr. 2
Yekaterinburg, 620000
Central city clinical hospital No. 1 of Oktyabrsky district
Yekaterinburg, 620026
City clinical hospital No. 14
Yekaterinburg, 620039
Central clinical hospital Nr. 3
Yekaterinburg, 620067
Medical Association "Novaya Bolnitsa" Polyclinic
Yekaterinburg, 620109
Central City Hospital Nr.7
Yekaterinburg, 620137
Czechia77 sites
MUDr. Alena Jelinkova
Bílina, 418 01
MUDr. Eva Krizova
Boskovice, 68001
Ambulance pro nemoci plicni a TBC, s.r.o.
Brno, 60200
Jana Jančíková
Brno, 60200
MUDr Hana Vašínová
Brno, 60200
MUDr. Ilona Binkova
Brno, 60200
MUDr. Jana Slapnickova s.r.o.
Brno, 60200
MUDr. Jaroslava Lovakova
Brno, 60200
MUDr. Michal Svarc
Broumov, 55001
Plicní Čáslav s.r.o.
Čáslav, 28601
MUDr. Jan Faktor Medipont s.r.o.
České Budějovice, 370 01
MUDr. Josef Hlavac Medipont s.r.o.
České Budějovice, 370 01
MUDr. Martin Polasek
CeskyTesinKonakov, 735 62
MUDr. Renata Bilkova
Děčín, 40502
MUDr. Jiri Guthwirth
Dobřís, 26301
MUDr. Martin Adamec Alergonet Group
Frýdek-Místek, 738 01
MUDr. Marie Buresova
Havlíčkův Brod, 580 01
MUDr. Jana Psikalova
Holešov, 76901
MUDr. Stanislava Bednarova
Holešov, 76901
MUDr. Petr Šafránek
Hořovice, 268 31
MUDr. Hana Lochmanova AXIMED s.r.o.
Hradec Králové, 500 02
MUDr. Ales Bohac Plicni ambulance
Hranice, 753 22
MUDr. Lenka Fousova
Hustopece U Brna, 693 01
MUDr. Bohumil Kralicek
Jihlava, 586 01
MUDr. Jirina Knillova
Jihlava, 586 01
MUDr. Alexandra Woznicova
Jirkov, 431 11
MUDr. Michaela Baerova
Kosmonosy, 293 06
MUDr. Petr Kolman
Kyjov, 69701
MUDr. Milanda Sipkova
Liberec, 460 05
Plucni Ambulance Louny s.r.o.
Louny, 44001
MUDr. Ilona Pavlisova, s.r.o.
Miroslav, 67172
MUDr. Michaela Baerova
Mlada Boreslav, 29301
MUDr. Pavla Shihatova
Náchod, 547 01
MUDr. Dusan Velart
Nový Jičín, 741 01
MUDr. Sarka Hofrova
Nový Jičín, 741 01
MUDr. Sarka Klimesova
Nymburk, 288 01
MUDr. Ondrej Sobotik
Olomouc, 779 00
MUDr. RAdoslav Alexa
Orlová - Lutyně, 735 14
MUDr. Milena Sramkova
Ostrava, 700 30
MUDr. Jana Balounova
Ostrava, 70868
MUDr. Jana Kocianova
Ostrava, 70868
Plicní-ambulance Terezie Janásková, s.r.o
Ostrava, Bělský Les, 700 30
MUDr. Tereza Dobesova Aximed s.r.o.
Pardubice, 530 02
MUDr. Miluse Zitkova
Pardubice, 530 09
MUDr. Jiri Zoula Aries Medici s.r.o.
Pelhřimov, 396 01
MUDr. Petr Hartman
Pilsen, 301 00
MUDr. Jitka Smolova
Pilsen, 30100
MUDr. Vladimir Makrlik
Pilsen, 30100
MUDr. Petr Šafránek
Pilsen, 312 00
MUDr. Andrea Svabkova
Pilsen, 323 00
MUDr. Jana Janková Zátopková
Poděbrady, 290 01
MUDr. Olga Krizova
Pohořelice, 691 23
První plicní ambulance s.r.o.
Prague, 11000
MUDr. Fransitek Petrik
Prague, 120 00
MUDr. Romana Davidova
Prague, 14800
MUDr. Iva Stachova
Prague, 150 00
MUDr. Ivana Zatloukalova
Prague, 150 00
MUDr. Milada Typltová
Prague, 161 00
MUDr. Ivana Jirmanova
Prague, 16200
MUDr. Jana Jirouskova
Prague, 169 00
MUDr. Lenka Povysilova
Prague, 169 00
MUDr. Vera Reichmanova
Prague, 170 00
MUDr. Vera Pacovska
Prague, 17000
MUDr. Bronislava Viest
Prague, 19061
MUDr. Ivana Boučková
Prague, 19800
MUDr. Romana Ivankova
Prostějov, 79601
MUDr. Helena Ringlerova
Rokycany, 33701
MUDr. Jaroslav Mares
Strakonice, 386 01
MUDr. Margit Hóracková
Šumperk, 78701
MUDr. Alena Kortusova
Ústí nad Labem, 400 01
MUDr. Olga Martinkovicova
Ústí nad Labem, 419 01
MUDr. Pavel Stach
Valašské Meziříčí, 75701
MUDr. Eva Sabova
Veselí nad Moravou, 69801
MUDr. Pavel Matuska
Zábřeh, 78901
MUDr. Jiri Dolecek
Žamberk, 564 01
MUDr. Michal Pasler
Žamberk, 56401
MUDr. Alena Prochazkova
Židlochovice, 667 01
Poland48 sites
Specjalistyczy Gabinet Lekarski Urszula Świetlik Malesa
Biała Podlaska, 21-500
ISPL Beata Kuklińska
Bialystok, 15-003
Poradnia Chorób Płuc Samodzielny Publiczny Zakład Opieki Zdrowotnej"Szpital Powiatowy"W Bochni
Bochnia, 32-700
Indywidualna Praktyka Lekarska Aleksandra Burysz
Bydgoszcz, 85-324
Specjalistyczna Praktyka Lekarska Choroby Płuc Agata Kalicka
Bydgoszcz, 85-915
Indywidualna Specjalistyczna Praktyka Lekarska Dr. n. med. Szymon Dworniczak
Chorzów, 41-500
Indywidualna Specjalistyczna Praktyka Lekarska Anna Góra-Florek
Ciecierzyn, 21-003
ODM Gdynia
Gdynia, 81-363
Gabinet lekarski Renata Pejas-Dulewicz
Gmina Końskie, 26-200
Specjalistyczna Praktyka Lekarska i USG
Jasło, 38-200
Specjalistyczny Gabinet Lekarski Juliusz Bokiej
Jelenia Góra, 58-500
Niepubliczny Zakład Opieki Specjalistycznej "Zdrowe Płuca"
Kielce, 25-528
Indywidualna Specjalistyczna Praktyka Lekarska lek. Krzysztof Lis
Kielce, 25-751
Lekarskie Wizyty Domowe Jarosław Zięba
Kłomnice, 42-270
Gabinet lekarski Wojciech Machowiak
Kościan, 64000
Specjalistyczny Zespół Gruźlicy i chorób Płuc
Koszalin, 75-252
Poradnia Chorób płuc
Krakow, 30-901
Indywidualna Praktyka Lekarska Aleksander Kania
Krakow, 31-443
Gabinet lekarski Thomasz Mysior
Krakow, 31-619
Uniwersytecki Szpital Kliniczny Nr 1
Lodz, 90-153
Centrum Leczenia Chorób Płuc w Łodzi
Lodz, 91-520
Przychodnia Specjalistyczna Snzoz Med Med. Sp.Z O.O
Lodz, 93-219
Specjalistyczna Praktyka Lekarska Piotr Kamiński
Lublin, 20-086
Alergopneuma sp. Z.o.o.
Lublin, 20-089
ISPL Łukasz Minarowski
Olmonty, 15-603
Prywatny gabinet lakarski Izabela Piętowska-Łazuka
Parczew, 21-200
Medycyna-diagnostyka Adam Nowiński
Piaseczno, 05-500
Gabinet lekarski Edyta Kozińska
Płock, 09-408
MEDICAL-MED. Indywidualna Specjalistyczna Praktyka Lekarska Barbara Kuźnar-Kamińska
Poznan, 60-313
Indywidualna Specjalistyczna Praktyka Lekarska Magdalena Kostrzewska
Poznan, 60-750
Poradnia Gruźlicy i Chorób Płuc SPZOZ Proszowice
Proszowice, 32-100
Gabinet lekarski Roman Masarczyk
Pyskowice, 44-120
Szpital Rejonowy im.dr Rostka-Oddził Pulmonologiczny
Racibórz, 47-400
Podkarpackie Centrum Chorób Płuc
Rzeszów, 35-241
Gabinet lekarski Choroby płuc i oskrzeli Joanna Tęsiorowska
Sieradz, 98-200
NZOZ Poradnia Chorób Płuc i Alergologii
Słupsk, 76-200
Indywidualna Specjalistyczna Praktyka Lekarska Krzysztof Filipek
Sosnowiec, 41-200
NZOZ Centrum Medyczne SBB
Tarnobrzeg, 39-400
Viltis Medica Spejalistyczan Praktyla Lekarska lek.med. Agata Kot
Trzebnica, 55-100
STANMED Gabinet Lekarski Robert Staniszewski
Warsaw, 00-201
Instytut Gruźlicy i Chorób Płuc
Warsaw, 01-164
Gabinet lekarski Beata Żołnowska
Warsaw, 01-631
MSWiA
Warsaw, 02-507
Wizyty Domowe Internisty B. Homola-Piekarska
Warsaw, 03-984
Gabinet lekarski Andrzej Jaworski
Warsaw, 04-907
Gabinet Internistyczny-Choroby płuc lek.med.M.Kraszewska
Wieruszów, 98-400
Specjalistyczna Praktyka Lekarska dr n.med. Andrzej Obojski
Wroclaw, 51-664
Specjalistyczny Szpital Chorób Płuc Odrodzenie im Klary Jelskiej
Zakopane, 34-500
Hungary35 sites
Ecce Homo Orvosi Bt.
Balassagyarmat, 2660
Dr. Major Katalin IZOPULM Kft.
Budapest, 1011
FOKUSZ-PULMO Egeszsegügyi, Kutatasi, Oktatoi Tanacsado Bt
Budapest, 1025
Kineto-Med Bt.
Budapest, 1032
Dr. Szabó Gyöngyi
Budapest, 1119
Dr. Szilvia Vasas
Budapest, 1122
Emósi Bt.
Budapest, 1165
Főv.XIX.ker.Önk.Egészségügyi Int
Budapest, 1191
Dr. Zoltan Gyula Bende
Budapest, 1220
Fenykepzeles KFT
Csitár, 2673
Electro-Medic Bt.
Debrecen, 4028
Rizikó '99
Debrecen, 4028
Szent Pantaleon Hospital
Dunaújváros, 2400
Pulmo Bt.
Edelény, 3780
Dr. Gyetvainé Dr. Lanczki Éva
Eger, 3300
Dr. Kontz Katalin
Gyöngyössolymos, 3231
Dr. Szász Zoltán
Győr, 9021
Györ Tüdögondozo
Győr, 9023
Broncho-Vin BT.
Gyula, 5700
Pulmoport Kft.
Gyula, 5700
Rakvács-Mózes Bt.
Kaposvár, 7400
Selye János Kórház, Rendelőintézet, Tüdőgondozó
Komárom, 2900
Sz.-Sz.-B. MK és EOK. Mátészalka
Mátészalka, 4700
Borsod-Abaúj-Zemplén Megyei Központ Kórház és Egyetemi Oktatókórház Semmelweis Tagkórház
Miskolc, 3529
Dr. Bíró Margit
Monok, 3905
Monor Szakrendelö Tüdögondozo
Monor, 2200
Infer-Med Kft
Nagykozár, 7741
Dr. Varga Ágnes
Pécs, 7625
Ujpesti Szakorvosi Rendelöintezet
Pócsmegyer, 2017
Dr. Anna Bartha
Siófok, 8600
Dr. Breining és Társa Egészségügyi Szolgáltató Bt.
Sopron, 9400
Dr. Radeczky Éva
Százhalombatta, 2440
Dr. Bánvölgyi Aranka Milassinné
Szeged, 6728
Dr. Geherne Dr. Huszar Hermina Eveline
Szombathely, 9700
Szabolcs-Szatmár-Bereg Megyei Kórházak és Egyetemi Oktatókórház
Vásárosnamény, 4800
Romania28 sites
DaniPneumoMed SRL
Arad, 315200
Butacel F. Maria Danisia - Medic Specialist Pneumolog
Bacau, 600148
Manolache Cristina - Medic Specialist Pneumologie
Bistrița, 420080
Dr. Bendas Magdalena
Botoșani, 710336
Muresan Alina Pneumoconsult Srl
Brasov, 500295
Dr Cosei Valentin-Caius Pfi
Bucharest, 31746
Borcea Corina-Ioana Persoana Fizica Autorizata
Bucharest, 61191
Ispas Elena-Irina Medic Specialist Pneumolog
Bucharest, 61593
Pneumo Clinic Care SRL
Constanța, 900621
Crm Pneumology Srl
Craiova, 200501
Nicolosu Med Srl
Craiova, 200677
Avencord SRL
Focşani, 620003
Miron V. Ramona - Medic Colaborator
Iași, 700233
Howas Med Srl
Jud Constanta, 38079525
Ciumarnean G Lorena Medic Specialist
Jud. Cluj, Mun. Cluj-Napoca, 400414
Chis P Ana Florica - Medic Specialist Pneumologie
Jud. Cluj, Mun. Cluj-Napoca, 400426
Cabinet Medical Individual Defta I. Doina-Elisabeta
Jud. Giurgiu , Mun. Giurgiu, 80121
Rarcolmed Srl
Milcovul, 30167
Vlad M. Elena - Medic Primar Pneumolog
Mun. Târgu Jiu, 210164
Medic Primar Pneumologie Stoleru Manuela
Piatra Neamţ, 610255
Raissa Maria Medical Srl
Popeşti-Leordeni, 77160
PFI Chirea C. Monica Valentina
Râmnicu Sărat, 5273
Viosan-Resp S.R.L.
Râmnicu Vâlcea, 167473
Jager Pneumo Services Srl
Sat Ariniș, 437010
Sc Nexus Medical Srl
Sat Visan, Jud Iasi, 700285
Cabinet Medical Individual Dr. Butuc Lilia
Tg.Lăpuș, 435600
Cabinet Medical Pneumologie Dr. Albu Claudia
Timișoara, 300587
CMI Dr. Mihailescu Constantin
Vânju-Mare, 225400
Israel23 sites
ASSUTA Ashdod Ltd.
Ashdod, 77000
Barzilai Medical Center
Ashkelon, 78306
Clalit - Bat Yam
Bat Yam, 5962026
Soroka Medical Center
Beersheba, 85025
Hillel Yaffe Medical Center
Hadera, 38100
Carmel Medical Center
Haifa, 3436212
Edith Wolfson Medical Center
Holon, 5810001
Maccabi Healthcare
Holon, 5837737
Shaarei Zedek Medical Center
Jerusalem, 91031
Research Fund of the Hadassah Medical Organization (R.A.)
Jerusalem, 9112001
Clalit - Jerusalem East
Jerusalem East, 9103102
Meir Medical Center Israel
Kfar Saba, 4428164
Holy Family Hospital
Nazareth, 16234
Rabin Medical Center (Beilinson Hospital)
Petah Tikva, 4941492
Clalit Health Services
Petah Tikva, 49473
Kaplan Medical Center
Rehovot, 76100
Health Corporation of the Ziv Medical Center (R.A.)
Safed, 13100
Clalit - Nazareth
Tel Aviv, 62098
Clalit - Rishon
Tel Aviv, 62098
Clalit - Carmiel
Tel Aviv
Sheba Medical Center
Tel-Hashomer / Ramat Gan, 5262000
PORIYA Medical Center
Tiberias, 15208
Assaf Harofeh MC
Zrifin, 70300
Slovenia19 sites
Internistična ambulanta za pljučne in alergijske bolezni Karmen Kramer Vrščaj
Celje, 3000
Pulmološka ambulanta dr. Snežana Ulčar Kostič s.p.
Kamnik, 1241
MEDICOINTERNA, medicinske storitve in svetovanje, d.o.o.
Kočevje, 1330
VELOG, Zdravstveni center, d.o.o.
Kranj, 4000
Zdravstvene storitve in svetovanje, Tjaša Šubic s.p.
Kranj, 4000
Verboten Kopriva Renata - Ordinacija Interne Medicine
Litija, 1270
Arjana Maček d.o.o
Ljubljana, 1000
Kambič-Kafol d.o.o.
Ljubljana, 1000
Medvital Katarina Vukelič s.p.
Ljubljana, 1000
Alveola, internistični ambulantni diagnostični center d.o.o.
Maribor, 2000
CIIM PLUS, center za interno in interventno medicino, d.o.o.
Maribor, 2000
INTERNIST MB - specialistična ambulantna dejavnost, Marko Bombek s.p.
Maribor, 2000
Zdravstveno svetovanje in storitve, Krstić Zoran, s.p.
Maribor, 2000
Mag. Anton Lopert, dr.med. - Zasebna internistična ambulanta
Murska Sobota, 9000
Zasebna ambulanta za pljučne bolezni, mag. Alojz Horvat, dr. med.
Murska Sobota, 9000
Prim. mag. Šegota Nikša, dr.med., specialistična zdravniška dejavnost, s.p.
Škofja Vas, 3211
Dr. Ana Novakovic
Velenje, 3320
Dr. med. Tomaz Smonkar
Velenje, 3320
Dr. Mikro Lekic
Velenje, 3320
Bulgaria17 sites
MBAL Sveti Ivan Rilski-2003
Dupnitsa, 2600
SBALBB "Pencho Semov" - Gabrovo EOOD
Gabrovo, 5300
SBALPFZ Haskovo EOOD
Haskovo, 6300
MBAL Kiro Popov EOOD
Karlovo, 4300
MBAL Sv. Ivan Rilski EOOD
Kozloduy, 3320
MBAL "Prof. Dr P. Stoyanov" AD - Mihail Kirov
Lovech, 5500
Iliana Valkanova
Plovdiv, 4002
MBAL Sveti Panteleimon
Plovdiv, 4004
"Medical Center-Razgrad"OOD
Razgrad, 7200
Medical Center Re Spiro OOD
Razgrad, 7200
MBAL Sliven to VMA Sofia
Sliven, 8800
Grigor Lalov
Smolyan, 4700
SBALPFZ-Sofia district EOOD
Sofia, 1202
Prevencia 2000 MCDMP OOD
Stara Zagora, 6000
Medical Center "Research expert" OOD
Varna, 9000
Medical Center "Tara" OOD
Veliko Tarnovo, 5000
MC"Sv.Ivan Rilski"OOD
Vidin, 3700
Switzerland7 sites
Gruppenpraxis Basel
Basel, 4051
Gruppenpraxis Frick
Frick, 5070
Gruppenpraxis Emmenbrücke
Geuensee, 6232
Berner Reha Zentrum Medizin Pneumologie
Heiligenschwendi, 3625
Gruppenpraxis Luzern
Lucerne, 6004
Spital Linth
Utznach, 8730
Zürcher RehaZentrum Wald
Wald, 8636
Ukraine7 sites
Dnipropetrovsk 6 City clinical Hospital
Dnipropetrovsk, 49074
Regional centre of Phtysiology and Pulmonology
Ivano-Frankivsk, 76018
City Clinical Hospital Nr. 13
Kharkiv, 61001
National Institute of Phthisiology and Pulmonology named F. G. Yanovsky National Academy of Medical Sciences of Ukraine
Kyiv, 3038
Volyn Regional Clinical Hospital
Lutsk, 43000
Lviv Regional Phthisiopneumological Clinical Treatment and Diagnostic Center
Lviv, 79000
Vinnytsia City Clinical Hospital Nr. 1
Vinnitsa, 21029
Lithuania5 sites
Hospital of Lithuanian University of Health Sciences Kauno klinikos
Kaunas, LT- 50161
Klaipeda Hospital
Klaipėda, 92231
Enterprise Klaipeda University Hospital
Klaipėda, 92288
Vilnius University Hospital Santaros klinikos
Vilnius, 8661
Public Enterprise Vilnius District Central Outpatient Clinic
Vilnius, LT-06122
About this study
Official title: Changes in Clinical Control of COPD Patients Measured by the Clinical COPD Questionnaire During Therapy With Spiolto®Respimat® in Routine Clinical Practice
Open-label observational study which includes COPD patients that are receiving treatment with Spiolto® Respimat® for approximately 6 weeks, which is the average time between two medical consultations.
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Being tested
- Spiolto® Respimat®
- Medical subject headings
- Pulmonary Disease, Chronic Obstructive
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Spiolto® Respimat®Drug
Drug
| Study group | Role | What they receive |
|---|---|---|
| subjects with COPD | Not described Receives: Drug: Spiolto® Respimat® |
What is being measured
The primary outcome is the main question the study is designed to answer.
Percentage of Patients With Therapeutic Success of Spiolto® Respimat® Treatment at Visit 2
Therapeutic success of Spiolto® Respimat® treatment was defined as 0.4 point decrease in the Clinical Chronic Obstructive Pulmonary Disease (COPD) Questionnaire - Clinical COPD Questionnaire (CCQ) score from visit 1 to visit 2. Each of the 10 CCQ questions is scored by the patient on a 7-point scale between 0 (Never/Not limited at all) and 6 (Almost all the time/Totally limited or unable to do) at baseline (Visit 1) and at the end of the observation after approximately 6 weeks (Visit 2). The sum of the scores divided by 10 gives the CCQ score, which measures the health and functional status. A higher CCQ score is indicative of worse status.
Measured: At Visit 2 (6 weeks after baseline visit 1)
Secondary outcomes (7)
Changes in the Clinical COPD Questionnaire (CCQ) and the CCQ Symptom, Mental State and Functional State Domain Scores From Visit 1 (Baseline) to Visit 2
The CCQ questionnaire contained 10 questions about symptoms, functional status and mental status. Each of the 10 CCQ questions was scored by the patient on a 7-point scale between 0 and 6 at baseline and at the end of observation after approximately 6 weeks. Symptom domain covered 4 questions (number 1, 2, 5, 6), Functional state domain covered 4 questions (number 7, 8, 9, 10), and Mental state domain covered 2 questions (number 3, 4). Scores for the questions in each domain were summed up and divided by the number of questions in each domain giving the resulting score for respective domain. The sum of the scores divided by 10 gives the CCQ score which measures the health and functional status. A higher CCQ score is indicative of worse status. Change of the score was calculated as visit 2 minus visit 1.
Measured: At baseline visit 1 and 6 weeks thereafter at visit 2
Physician's Global Evaluation (PGE) Score at Visit 1(Baseline)
PGE score assessed the general condition of the patient on an 8-point ordinal scale from 1 (very poor) to 8 (excellent).
Measured: At visit 1
Physician's Global Evaluation (PGE) Score at Visit 2
PGE score assessed the general condition of the patient on an 8-point ordinal scale from 1 (very poor) to 8 (excellent).
Measured: At visit 2 (6 weeks after baseline visit 1)
Patient Overall Satisfaction With Spiolto® Respimat® Treatment at Visit 2
Patient overall satisfaction with Spiolto® Respimat® treatment at visit 2 was reported.
Measured: At visit 2 (6 weeks after baseline visit 1)
Patient Satisfaction With Inhaling From the Respimat® Device at Visit 2
Patient satisfaction with inhaling from the Respimat® device at visit 2 was reported
Measured: At visit 2 (6 weeks after baseline visit 1)
Patient Satisfaction With Handling of the Respimat® Inhalation Device at Visit 2
Patient satisfaction with handling of the Respimat® inhalation device at visit 2 was reported.
Measured: At visit 2 (6 weeks after baseline visit 1)
Number of Participants Willing to Continue Treatment With Spiolto® Respimat® at Visit 2
Number of participants willing to continue treatment with Spiolto® Respimat® at visit 2 was reported.
Measured: At visit 2 (6 weeks after baseline visit 1)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Sep 2018
- Study start15 Aug 2018
- Primary completion4 Oct 2019
- Study completion4 Oct 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Pulmonary Disease, Chronic ObstructiveStudies of the same condition, open and under way.
- More trials run by Boehringer IngelheimThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Prospective
- Enrolment
- 4,819 participants (actual)
Sponsor and investigators
- Lead sponsor
- Boehringer Ingelheim
- Sponsor type
- Industry (pharma, biotech, devices)
- Responsible party
- Sponsor
- Investigators
- Alexey Medvedchikov, +431801057896, Study chair, alexey.medvedchikov@boehringer-ingelheim.com
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03663569
- Sponsor's protocol ID
- 1237-0072
- Status last verified
- Dec 2024
- First submitted
- 26 Jul 2018
- Last updated
- 7 Jan 2025
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
- FDA-regulated drug
- Yes
- FDA-regulated device
- No
- Individual data sharing
- Undecided: Clinical studies sponsored by Boehringer Ingelheim, phases I to IV, interventional and non-interventional, are in scope for sharing of the raw clinical study data and clinical study documents, except for the following exclusions: 1. studiesin products where Boehringer Ingelheim is not the license holder; 2. studies regarding pharmaceutical formulations and associated analytical methods, and studies pertinent to pharmacokinetics using human biomaterials; 3. studies conducted in a single center or targeting rare diseases (because of limitations with anonymization).Requestors can use the following link http://trials.boehringer-ingelheim.com/ to: 1. find information in order to request access to clinical study data, for listed studies. 2. request access to clinical study documents that meet criteria, and upon a signed 'Document Sharing Agreement'
Study at a glance
From the registry record, last updated by the sponsor on 7 Jan 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Changes in Clinical Control of COPD Patients Measured by the Clinical COPD Questionnaire During Therapy With Spiolto®Respimat® in Routine Clinical Practice
- ClinicalTrials.gov ID
- NCT03663569
- Acronym / sponsor ID
- 1237-0072
- Conditions
- Pulmonary Disease, Chronic Obstructive
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 4,819 participants (actual)
- Lead sponsor
- Boehringer IngelheimIndustry (pharma, biotech, devices)
- Study start
- 15 Aug 2018 (actual)
- Primary completion
- 4 Oct 2019 (actual)
- Study completion
- 4 Oct 2019 (actual)
- First posted
- 10 Sep 2018 (actual)
- Results
- Posted 22 Oct 2020
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Open-label observational study which includes COPD patients that are receiving treatment with Spiolto® Respimat® for approximately 6 weeks, which is the average time between two medical consultations.
Study design
- Observational model
- Other
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| subjects with COPD | – | Drug: Spiolto® Respimat® |
Who may qualify
- Ages
- 40 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Around 4500 COPD patients from approximately 11 countries will be collected, with a signed informed consent will be maintained in the ISF at the investigational site irrespective of whether they have been treated or not.
Key inclusion criteria (3 listed)
- Written informed consent prior to participation
- Female and male patients ≥40 years of age
- Patients diagnosed with COPD and based upon the investigator's decision requiring a new prescription of Spiolto Respimat® (combination of two long-acting bronchodilators) according to Spiolto® Respimat® SmPC, GOLD COPD Strategy Document 2018 (GOLD COPD groups B to D) and local COPD guidelines
Key exclusion criteria (5 listed)
- Patients with contraindications according to Spiolto® Respimat® SmPC
- Patients already on a LABA/LAMA combination (free and fixed dose) in the last 6 weeks before study entry
- Patients continuing LABA/ICS treatment should not be additionally treated with Spiolto® Respimat® in order to avoid a double dosing of long-acting beta-agonists
- Pregnancy and lactation
- Current participation in any clinical trial or any other non-interventional study of a drug or device.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Spiolto® Respimat®Drug | Drug | subjects with COPD |
Primary outcome
Percentage of Patients With Therapeutic Success of Spiolto® Respimat® Treatment at Visit 2
Time frame: At Visit 2 (6 weeks after baseline visit 1)
Therapeutic success of Spiolto® Respimat® treatment was defined as 0.4 point decrease in the Clinical Chronic Obstructive Pulmonary Disease (COPD) Questionnaire - Clinical COPD Questionnaire (CCQ) score from visit 1 to visit 2. Each of the 10 CCQ questions is scored by the patient on a 7-point scale between 0 (Never/Not limited at all) and 6 (Almost all the time/Totally limited or unable to do) at baseline (Visit 1) and at the end of the observation after approximately 6 weeks (Visit 2). The sum of the scores divided by 10 gives the CCQ score, which measures the health and functional status. A higher CCQ score is indicative of worse status.
7 secondary outcomes
Changes in the Clinical COPD Questionnaire (CCQ) and the CCQ Symptom, Mental State and Functional State Domain Scores From Visit 1 (Baseline) to Visit 2
Time frame: At baseline visit 1 and 6 weeks thereafter at visit 2
Physician's Global Evaluation (PGE) Score at Visit 1(Baseline)
Time frame: At visit 1
Physician's Global Evaluation (PGE) Score at Visit 2
Time frame: At visit 2 (6 weeks after baseline visit 1)
Patient Overall Satisfaction With Spiolto® Respimat® Treatment at Visit 2
Time frame: At visit 2 (6 weeks after baseline visit 1)
Patient Satisfaction With Inhaling From the Respimat® Device at Visit 2
Time frame: At visit 2 (6 weeks after baseline visit 1)
Patient Satisfaction With Handling of the Respimat® Inhalation Device at Visit 2
Time frame: At visit 2 (6 weeks after baseline visit 1)
Number of Participants Willing to Continue Treatment With Spiolto® Respimat® at Visit 2
Time frame: At visit 2 (6 weeks after baseline visit 1)
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 7 Jan 2025.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Individual participant dataSharing planned: Undecided. Clinical studies sponsored by Boehringer Ingelheim, phases I to IV, interventional and non-interventional, are in scope for sharing of the raw clinical study data and clinical study documents, except for the following exclusions: 1. studiesin products where Boehringer Ingelheim is not the license holder; 2. studies regarding pharmaceutical formulations and associated analytical methods, and studies pertinent to pharmacokinetics using human biomaterials; 3. studies conducted in a single center or targeting rare diseases (because of limitations with anonymization).Requestors can use the following link http://trials.boehringer-ingelheim.com/ to: 1. find information in order to request access to clinical study data, for listed studies. 2. request access to clinical study documents that meet criteria, and upon a signed 'Document Sharing Agreement'
Related trials for Pulmonary Disease, Chronic Obstructive
Enrolling by invitationObservational study
Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES)
Anosmia, Chronic Obstructive Pulmonary Disease
RecruitingPhase 3
A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
Chronic Graft-versus-host-disease
Not yet recruiting
Impact of Multidisciplinary Care, Structured and Targeted on the COPD Patient's Clinical Pathway.
Chronic Obstructive Pulmonary Disease, Lung Diseases, Obstructive
Not yet recruitingPhase 3
The AIRWARD Study: A Study to Test Whether Verducatib Helps People With Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease
Not yet recruiting
Evaluating and Promoting Resilience in Adolescents With Tourette Syndrome
Tourette Syndrome, Tic Disorders
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Alexey Medvedchikov, +431801057896 study chair
alexey.medvedchikov@boehringer-ingelheim.com
388 sites in 11 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Pulmonary Disease, Chronic Obstructive, run by Boehringer Ingelheim at 388 sites in 11 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 7 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 388 sites in Russia, Czechia, Poland, Hungary, Romania and 6 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 22 Oct 2020). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percentage of Patients With Therapeutic Success of Spiolto® Respimat® Treatment at Visit 2 (time frame: At Visit 2 (6 weeks after baseline visit 1)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jan 2025.